The patient or a legally authorized representative must provide study-specific informed consent prior to step registration The patient or a legally authorized representative must provide study-specific informed consent prior to study entry. The patient or a legally authorized representative must provide study-specific informed consent prior to study entry The patient or a legally authorized representative must provide study-specific informed consent prior to study entry The patient or a legally authorized representative must provide study-specific informed consent prior to study entry Patients or their legally authorized representative must provide written informed consent Documented informed consent of participant and/or legally authorized representative Must sign study-specific, IRB approved informed consent form prior to study entry. Note consent by legally authorized representative is not allowed for this trial. The participant (or legally authorized representative, if applicable) must be willing and able to provide written informed consent for the trial Documented informed consent of participant and/or legally authorized representative The patient or legally authorized representative must provide study-specific informed consent prior to study entry Documented informed consent of the participant or legally authorized representative Patient must have the ability to understand the requirements of the study and signed informed consent. A signed informed consent by the patient or his legally authorized representative is required\r\nprior to their enrollment on the protocol Patients or their legally authorized representative must provide written informed consent Documented informed consent of the participant and/or legally authorized representative Documented informed consent of the subject and/or legally authorized representative Patients or their legally authorized representative must provide written informed consent Able to understand the potential risks, benefits, and requirements of the study and are willing to provide informed consent; an informed consent form for this study that is signed by the patient or his/her legally authorized representative is required prior to enrollment Able to understand the potential risks, benefits, and requirements of the study and are willing to provide informed consent; an informed consent form for this study that is signed by the patient or his/her legally authorized representative is required prior to enrollment Patients or their legally authorized representative must provide written informed consent Patients or their legally authorized representative must have the ability to understand and provide signed informed written consent Patients or their legally authorized representative must provide written informed consent Patients or their legally authorized representative must provide written informed consent Patients or their legally authorized representative must provide written informed consent Patients or their legally authorized representative must provide written informed consent Patients or their legally authorized representative must provide written informed consent Patient or legally authorized representative able to sign informed consent Patients or their legally authorized representative must provide written informed consent Patient, legally authorized representative (LAR), or parent able to sign informed consent; able to give assent for patients age - Patient must have the ability to understand the requirements of the study and signed informed consent a signed informed consent by the patient or his legally authorized representative is required prior to their enrollment on the protocol Patient or legally authorized representative able to sign informed consent Must sign study-specific, IRB approved informed consent form prior to study entry. Note consent by legally authorized representative is not allowed for this trial. Patient or legally authorized representative able to sign informed consent Patient must have the ability to understand the requirements of the study and signed informed consent; a signed informed consent by the patient or his legally authorized representative is required prior to their enrollment on the protocol Patient must have the ability to understand the requirements of the study and signed informed consent; a signed informed consent by the patient or his legally authorized representative is required prior to their enrollment on the protocol Signed informed consent by the patient or legally authorized representative Voluntary written consent (adult or legally authorized representative; or parental/guardian) Cases involving subjects who are minors, pregnant or require an authorized representative for informed consent Documented informed consent of the participant and/or the legally authorized representative Documented informed consent of the participant and/or legally authorized representative Patient or legally authorized representative able to sign informed consent Patient must have the ability to understand the requirements of the study and signed informed consent; a signed informed consent by the patient or his legally authorized representative is required prior to their enrollment on the protocol The patient or a legally authorized representative must provide study-specific informed consent prior to study registration The patient or a legally authorized representative must provide study-specific informed consent prior to step registration The patient or a legally authorized representative must provide study-specific informed consent prior to study entry, including consent for mandatory tumor tissue, serum, and blood submission for immune correlatives (all patients) and p analysis (oropharyngeal cases only) The patient or a legally authorized representative must provide study-specific informed consent prior to step registration The patient or a legally authorized representative must provide study-specific informed consent prior to study entry Subject or Authorized Representative is unable to provide informed consent. Patients or their legally authorized representative must provide written informed consent Be willing and able to provide written informed consent/assent for the trial; consent may be obtained by legally authorized representative (LAR) according to the protocol Patients or their legally authorized representative must provide written informed consent Patients or their legally authorized representative must provide written informed consent Either the subject or his/her legally authorized representative be willing and able to provide written informed consent for the trial Written informed consent, Release of Medical Records Form and HIPAA reviewed and signed by patient or legally authorized representatives The patient must be willing and able to comply with all study protocol requirements. The patient or a legally authorized representative must fully understand all elements of the informed consent and have signed the informed consent according to institutional and federal regulatory requirements The patient or a legally authorized representative must provide study-specific informed consent prior to study entry Able to give informed consent, or their legally authorized representative can give informed consent Patient, or his/her legally authorized representative, is able to understand and provide informed consent. Patient or a legally authorized representative of a patient must be able and willing to sign informed consent document that has been approved by an IRB Patients or their legally authorized representative must provide written informed consent A written and voluntarily signed informed consent must be obtained from the patient or legally authorized representative, in accordance with local regulations, before the initiation of any study related procedures. The patient or legally authorized representative must be able to read and understand the informed consent form (ICF). Patient or legally authorized representative able to sign an informed consent form Patient or legally authorized representative able to sign informed consent A written and voluntarily signed informed consent must be obtained from the patient or legally authorized representative, in accordance with local regulations, before the initiation of any study related procedures. The patient or legally authorized representative must be able to read and understand the informed consent form (ICF). Documented informed consent of the participant and/or legally authorized representative Patients or their legally authorized representative must provide written informed consent Able to provide informed consent, or if the oncology physician determines the patient to not have decision-making capacity, a patient-designated health care proxy (or authorized representative per institutional policies) must sign consent by the baseline visit; if the participant is found to be impaired on the Blessed-Orientation Memory Concentration Test (BOMC) during screening; they must have a health care proxy or authorized representative to be eligible to enroll The patient or a legally authorized representative must provide study-specific informed consent prior to study entry Ability to understand and/or the willingness of the patient (or parent or legally authorized representative, if minor) to provide informed consent, using an institutionally approved informed consent procedure Documented informed consent of the participant and/or legally authorized representative Legally authorized representative consent Subject or authorized representative has provided informed consent. Participant/parent/legally authorized representative (LAR) unwilling to give written informed consent Decisionally impaired adults requiring a legally authorized representative Voluntary written consent signed by the subject (or the subjects legally authorized representative) Subject or legally authorized representative signs study-related informed consent document Patient or the patients legally authorized representative must provide written informed consent prior to registration and any study-related procedures Valid informed consent by subject or subjects legally authorized representative (LAR) Patient, or authorized representative signs a written Informed Consent form to participate in the study, prior to any study mandated determinations or procedure Patient, or authorized representative signs a written Informed Consent form to participate in the study, prior to any study mandated determinations or procedure